Offerpad Solutions OPAD 深 沪
等待开盘 04-03 09:30:00 美东时间
0.692
-0.009
-1.28%
华盛通- 最 高0.7086
- 今 开0.671
- 成交量 55.03万股
- 最 低 0.65
- 昨 收 0.701
- 总市值 3272.25万
- 52周最高 6.35
- 市盈率 静 --
- 换手率 1.16%
- 52周最低 0.5702
- 委 比 0.00%
- 总股本 4728.68万
- 历史最高 314.55
- 量 比 0.60
- 振 幅 8.36%
- 历史最低 0.5702
- 每 手 1
- 风险率 1.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Offerpad Introduces Scout And Henry, Ai Platforms Built To Make Every Home Transaction Smarter Company Anticipates Improved Conversion, Reduced Acquisition Risk, And Greater Capital Efficiency Across Every Stage Of The Home Transaction
BRIEF-Offerpad Introduces Scout And Henry, Ai Platforms Built To Make Every Home Transaction Smarter Company Anticipates Improved Conversion, Reduced Acquisition Risk, And Greater Capital Efficiency Across Every Stage Of The Home Transaction March 18 (Reuters) - Offerpad Solutions Inc OPAD.N : OFFER
03-18 20:52
Offerpad Solutions (OPAD) Receives a Hold from J.P. Morgan
In a report released yesterday, Dae Lee from J.P. Morgan maintained a Hold rati...
03-10 17:25
Offerpad Solutions Receives Noncompliance Notice From NYSE
Offerpad Solutions Inc. ("Offerpad" or the "Company") (NYSE:OPAD) today announced that it received notice from the New York Stock Exchange (the "NYSE") that it is not in compliance with Section 802.01C of the NYSE Listed
03-07 05:06
美股大行评级 | 大摩将应用材料目标价升至432美元；潜在涨幅200.0%！维尔生物科技获巴克莱升目标价至30美元，维持"超配"评级
今日重点评级关注：巴克莱：维持Vir Biotechnology"超配"评级，目标价从26美元升至30美元；巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从10美元升至11美元
02-26 09:30
Keefe, Bruyette & Woods Maintains Market Perform on Offerpad Solutions, Lowers Price Target to $1
Keefe, Bruyette & Woods analyst Ryan Tomasello maintains Offerpad Solutions (NYSE:OPAD) with a Market Perform and lowers the price target from $1.75 to $1.
02-25 22:03
BRIEF-Offerpad Solutions Inc Files For Mixed Shelf Of Up To $250 Million - SEC Filing
BRIEF-Offerpad Solutions Inc Files For Mixed Shelf Of Up To $250 Million - SEC Filing Feb 25 (Reuters) - Offerpad Solutions Inc OPAD.N : OFFERPAD SOLUTIONS INC: FILES FOR MIXED SHELF OF UP TO $250 MILLION - SEC FILING Source text: [ID:n0001193125-26-067592] Further company coverage: OPAD.N (( Reuter
02-25 19:06
Offerpad Solutions Pivots Toward Leaner, Fee-Driven Growth
Offerpad Solutions Inc. (($OPAD)) has held its Q4 earnings call. Read on for th...
02-25 08:24
Offerpad Q4 revenue misses estimates
Offerpad Q4 revenue misses estimates Overview Real estate solutions firm's Q4 revenue missed analyst expectations Company sold 312 homes in Q4, down 38% yr/yr Outlook Offerpad expects Q1 2026 revenue between $70 mln and $95 mln Company anticipates 250-300 real estate transactions in Q1 2026 Offerpad
02-24 05:21
Offerpad Solutions Sees Q1 Sales $70.000M-$95.000M vs $152.362M Est
Offerpad Solutions (NYSE:OPAD) sees Q1 sales of $70.000 million-$95.000 million vs $152.362 million analyst estimate.
02-24 05:12
Offerpad Solutions Q4 EPS $(0.24) Beats $(0.27) Estimate, Sales $114.118M Miss $116.465M Estimate
Offerpad Solutions (NYSE:OPAD) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.27) by 12.09 percent. This is a 61.9 percent increase over losses of $(0.63) per share from
02-24 05:11
